BofA analyst Tazeen Ahmad raised the firm’s price target on Incyte (INCY) to $104 from $90 and keeps a Buy rating on the shares. After having hosted the company’s new CEO and Head of R&D, the analyst came away “encouraged by the company’s confidence in their commercial execution and several shots on goal.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INCY: